One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery
NCT: NCT02823054 · TERMINATED
Brief Summary
Coronary artery bypass grafting is a current cardiac surgery. Internal thoracic artery is usually taking to restore coronary revascularization, and its dissection can lead to accidental or voluntary pleural effusions. Respiratory complications are frequent, due to the drainage required. In this study, the investigators propose one-lung ventilation to facilitate artery grafting and surgical procedure. The investigators will include all adult patients with elective coronary artery bypass surgery (CABG) by internal thoracic artery, in a prospective, controlled, randomized and monocentric study. The main objective is to demonstrate that one-lung ventilation using EZ-Blocker can reduce pleural effusion defined by presence of drainage and/or pneumothorax on X-ray chest in the ICU.
Frequently Asked Questions
What is One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery?
One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery is a clinical trial registered under NCT02823054. Current status: TERMINATED.
What is the status of NCT02823054?
The current status of NCT02823054 (One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery) is: TERMINATED.
When did One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery start?
One-lung Ventilation During Internal Thoracic Artery Grafting in Cardiac Surgery started on 2017-01-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.